According to recent literature overexpression of miR-155 can strongly reduce TP53INP1 expression in cancers, and inhibition of miR-155 leads to the suppression of tumor growth in vitro and in vivo [27–29]. The gene discussed is TP53INP1; the disease is neoplasm.